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ABSTRACT
Uropathogenic isolates of Escherichia coli (UPEC) contain blocks of DNA, termed pathogenicity islands
(PAIs), that contribute to their virulence. Two multiplex PCR assays were developed to detect eight PAI
markers among 50 commensal E. coli and 100 UPEC isolates. In total, 40% of commensal isolates and
93% of UPEC carried PAIs. Despite this difference, the distribution of various PAIs showed the
same pattern in both groups, with the most prevalent being PAI IV536 (38% commensal vs. 89% UPEC),
followed by PAI ICFT073 (26% vs. 73%), PAI IICFT073 (14% vs. 46%), PAI IIJ96 (8% vs. 34%), PAI I536 (8%
vs. 33%) and PAI II536 (4% vs. 20%). PAI III536 was detected only in UPEC (2%), while PAI IJ96 was not
detected in any isolate. Although the mean number of PAIs per isolate was higher among UPEC (2.97)
than in commensal (0.98) isolates, there were no statistical differences among group B2 E. coli from the
two origins; however, commensal isolates from groups D and B1 appeared to be less virulent than
pathogenic isolates. Regardless of their phylogenetic group, nearly all the commensal and UPEC isolates
with the same number of PAIs had the same PAI combinations. Although group B2 E. coli are
uncommon among commensal intestinal flora, they are highly virulent when present, suggesting that
the intestinal flora may act as a reservoir for bacteria that can cause urinary tract infection.
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INTRODUCTION
Escherichia coli is one of the major causes of
extra-intestinal infections, such as cystitis, pyel-
onephritis, prostatitis, neonatal meningitis and
Gram-negative bacteraemia. It is also the most
common aerobic bacterium present among the
gut flora of healthy individuals. Extra-intestinal
pathogenic and commensal E. coli typically
differ with respect to ECOR phylogenetic group
and virulence attributes [1]. Pathogenic extra-
intestinal E. coli isolates belong chiefly to phy-
logenetic group B2 and, to a lesser extent, group
D, whereas commensal E. coli isolates belong to
groups A and B1 [2–4]. Moreover, pathogenic
extra-intestinal isolates harbour specialised viru-
lence factors, i.e., traits that confer pathogenic
potential, which are infrequent among commen-
sal isolates. The virulence factors are usually
encoded on pathogenicity islands (PAIs), provi-
ding a mechanism for coordinated horizontal
transfer of virulence genes [5]. The PAI concept
was first described in the late 1980s by Hacker
et al. [6,7]. PAIs are mobile genetic elements
made up of large blocks of DNA (> 10 kb)
inserted adjacent to tRNA genes, and usually
flanked by short direct repeats. PAIs contain
insertion sequences, integrases and transposases,
and have a G + C content that differs from the
host bacterial genome.
PAIs have been studied widely in the genomes
of pathogenic bacteria, but little attention has
been given to PAIs in the genomes of commensal
members of a species. To gain knowledge con-
cerning the occurrence of PAIs in commensal
isolates of E. coli, the present study investigated
the presence of various PAI markers in bacteria
isolated from the stools of healthy females, and
compared the results with those obtained with
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bacteria isolated from the urine of females with
urinary tract infection. The relationship between
the presence of these PAIs and the ECOR phylo-
genetic groups in commensal and uropathogenic
E. coli isolates was also analysed.
MATERIALS AND METHODS
Bacterial isolates
In total, 150 E. coli isolates were studied: 50 unrelated E. coli
isolates, selected following ERIC-PCR [8] from among 99
isolates obtained from the stools of 19 healthy females with no
symptoms of urinary tract infection (i.e., commensal isolates),
and 100 uropathogenic E. coli (UPEC), comprising 50 isolates
from patients with pyelonephritis and 50 isolates from patients
with urinary sepsis. The clinical characteristics of the UPEC
isolates have been described previously [2].
Detection of PAI markers by multiplex PCR
Two multiplex PCRs (A and B) were developed to detect the
eight most studied PAIs described in UPEC: PAI I and II in
E. coli J96; PAI I and II in E. coli CFT073; and PAI I–IV in E.
coli 536 [9,10] (Fig. 1). The virulence determinants encoded
on these different PAIs are: PAI I536, a-haemolysin, CS12
fimbriae and F17-like fimbrial adhesin; PAI II536, a-haemo-
lysin and P-related fimbriae; PAI III536, S-fimbriae and an
iron siderophore system; PAI IV536, yersiniabactin
siderophore system; PAI IJ96, a-haemolysin and P-fimbriae;
PAI IIJ96, a-haemolysin, Prs-fimbriae and cytotoxic necrotis-
ing factor 1; PAI ICFT073, a-haemolysin, P-fimbriae and
aerobactin; and PAI IICFT073, P-fimbriae and iron-regulated
genes [11].
With multiplex PCR A, three PAI markers were detected:
PAI III536, PAI IV536 and PAI IICFT073, yielding 0.2, 0.3 and 0.4-
kb fragments, respectively. With multiplex PCR B, five PAI
markers were detected: PAI IIJ96, PAI I536, PAI II536, PAI ICFT073
and PAI IJ96, yielding 2.3, 1.8, 1.0, 0.93 and 0.4-kb fragments,
respectively. The primers for PAI detection were selected
from PAI-associated sequences [7,12–14] (http://www.uni-
wuerzburg.de/infektionsbiologie), except for two primer
sequences that were designed specifically for this study
(Table 1). All the primer sequences were screened for similar-
ity to E. coli using BLASTN (http://www.ncbi.nlm.nih.gov/
BLAST) and were specific for the PAI sequences.
Multiplex PCR A contained 1.7 U Expand High Fidelity Taq
DNA polymerase in 1 · PCR buffer (Roche Diagnostics,
Barcelona, Spain), 0.5 mM dNTPs, 2.5 mM MgCl2, and the
following primer pool concentrations: 0.5 lM sfaAI.1, sfaAI.2,
IRP2.FP and IRP2.RP; and 0.7 lM cft073.2Ent1 and
cft073.2Ent2. Multiplex PCR B contained 2.4 U Expand High
Fidelity Taq DNA polymerase in 1 · PCR buffer, 0.5 mM
dNTPs, 3 mM MgCl2, and the following primer pool concen-
trations: 0.8 lM I.9 and I.10; 0.1 lM orf1up and orf1down;
0.04 lM papGIf and papGIr; 1.2 lM hlyd and cnf; and 0.06 lM
RPAi and RPAf. Template DNA (5 lL) was added to 45 lL of
the master mix. The program for both multiplex PCRs
consisted of 94C for 5 min, followed by 30 cycles of 94C
for 1 min, 55C for 1 min and 72C for 1 min, with a final
extension step at 72C for 10 min. Both PCRs were tested using
UPEC strains 536 and J96 as PAI marker controls.
Phylogenetic classification
Phylogenetic grouping of the E. coli isolates was done by a
simple, rapid PCR-based technique [15] that uses a combina-
tion of three DNA markers (chuA, yjaA and DNA fragment
tspE4.C2), generating 279, 211 and 152-bp fragments, respect-
ively. A triplex PCR was performed using the six primers in a
single reaction. The results of these three amplifications
allowed the classification of E. coli isolates into one of the
major phylogenetic groups: A, B1, B2 or D. E. coli strain RS218,
which belongs to phylogenetic group B2, was used as a control
[16].
Statistical methods
Comparisons of associations between PAI markers and ⁄ or
phylogenetic group were made using the chi-square test when
all expected cell frequencies were ‡ 5, chi-square with Yates’
IIJ96
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ICFT073
IV536
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(A) (B)1 2 3 4 5 6 7 1 2 3 4 5 6 78
Fig. 1. (A) Examples of multiplex PCR for detecting PAI markers IICFT073, III536, and IV536. Lanes: 1, Molecular Weight
Marker VIII (Roche Diagnostics); 2 - 5, E. coli isolates; 6 and 7, positive control E. coli J96 and E. coli 536, respectively; and 8,
negative control (reaction mix without added template DNA). (B) Examples of multiplex PCR for detecting PAI markers
I536, II536, IJ96, IIJ96, and ICFT073. Lanes: 1, Molecular Weight Marker III (Roche Diagnostics); 2 - 5, E. coli isolates; 6, positive
control E. coli J96; and 7, negative control (reaction mix without added template DNA).
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correction when any expected cell frequency was between 3
(included) and 5, and Fisher’s exact test (two-tailed) when any
expected cell frequency was < 3. Comparisons of means were
assessed using the Mann–Whitney U-test. Statistical analyses
were performed with SPSS v.10.0 (SPSS Inc, Chicago, IL, USA),
with significance set at p < 0.05.
RESULTS
Distribution of PAIs in commensal and
uropathogenic E. coli isolates
Overall, 20 (40%) of the 50 commensal isolates
selected for this study, and 93 (93%) of the 100
UPEC isolates, carried PAI markers. The most
prevalent PAI among commensal and UPEC
isolates was PAI IV536 (38% vs. 89%), followed
by PAI ICFT073 (26% vs. 73%), PAI I IICFT073 (14%
vs. 46%), PAI IIJ96 (8% vs. 34%), PAI I536 (8% vs.
33%) and PAI II536 (4% vs. 20%), respectively.
PAI III536 was detected only in the uropathogenic
group (2%), while PAI IJ96 was not detected in
any of the isolates studied.
Distribution of PAIs according to phylogenetic
group in commensal and uropathogenic E. coli
isolates
Classification of the commensal E. coli isolates
into phylogenetic groups revealed that Group B1
was the most common (34%), followed by Groups
D (28%) and A (20%), with Group B2 being the
least frequent (18%). Among the 100 UPEC
isolates, Group B2 was the most frequent (67%),
followed by Groups D (17%), A (11%) and B1
(5%). There was a significant positive association
between Group B2 and UPEC isolates, and
between Group B1 and commensal isolates
(p < 0.001).
Among the 20 commensal E. coli isolates
harbouring PAIs, nine (45%) belonged to Group
B2, five (25%) to Group D, three (15%) to
Group A, and three (15%) to Group B1. Among
the total of 48 PAIs detected in these 20 isolates,
73% were found in Group B2, 14.5% in Group
D, and 6.2% each in Groups A and B1. PAI
IV536 and PAI ICFT073 were predominant in all
the phylogenetic groups, and were the only
PAIs present in isolates from groups other than
Group B2 (Table 2).
Among the 93 UPEC isolates harbouring PAIs,
69 (74.2%) belonged to Group B2, 17 (18.3%) to
Group D, four (4.3%) to Group A and three
(3.2%) to Group B1. Among the total of 286 PAIs
detected in these 93 isolates, 88.8% were found in
Group B2, 8.4% in Group D, and 1.4% each in
Table 1. Primers for detection of
eight pathogenicity island markers
Target(s) Primer name Sequence (5¢-to 3¢) Reference
Multiplex PCR A PAI III536 sfaAI.1 CGG GCA TGC ATC AAT TAT CTT TG [12]
sfaAI.2 TGT GTA GAT GCA GTC ACT CCG
PAI IV536 IRP2 FP AAG GAT TCG CTG TTA CCG GAC [7]
IRP2 RP TCG TCG GGC AGC GTT TCT TCT
PAI IICFT073 cft073.2Ent1 ATG GAT GTT GTA TCG CGC PS
cft073.2Ent2 ACG AGC ATG TGG ATC TGC
Multiplex PCR B PAI I536
a I.9 TAA TGC CGG AGA TTC ATT GTC
I.10 AGG ATT TGT CTC AGG GCT TT
PAI II536
a orf1up CAT GTC CAA AGC TCG AGC C
orf1down CTA CGT CAG GCT GGC TTT G
PAI IJ96
b papGIf TCG TGC TCA GGT CCG GAA TTT [13]
papGIr TGG CAT CCC ACA TTA TCG
PAI IIJ96 hlyd GGA TCC ATG AAA ACA TGG TTA ATG GG [14]
cnf GAT ATT TTT GTT GCC ATT GGT TAC C
PAI ICFT073 RPAi GGA CAT CCT GTT ACA GCG CGC A [13]
RPAf TCG CCA CCA ATC ACA GC GAA C
PS, designed for present study. Primer coordinates cft073.2Ent1 28627–28644 and cft073.2Ent2 29047–29030, selected
from GenBank accession no. AF447814.
aPrimers selected from http://www.uni-wuerzburg.de/infektionsbiologie.
bPAI IJ96 has not been completely sequenced; papGI primers were used for detection of this PAI [13].
Table 2. Distribution of pathogenicity islands (PAIs)
among 50 commensal and 100 uropathogenic isolates of
Escherichia coli (UPEC), classified according to phylogenetic
group
Phylogenetic
group NT N
PAIs
I536 II536 III536 IV536 IJ96 IIJ96 ICFT073 IICFT073
Group B2
Commensal 9 9 4 2 0 9 0 4 9 7
UPEC 69 69 32 20 2 69 0 33 67 45
Group D
Commensal 14 5 0 0 0 4 0 0 3 0
UPEC 19 17 0 0 0 15 0 0 6 1
Group A
Commensal 10 3 0 0 0 3 0 0 1 0
UPEC 8 4 0 0 0 3 0 0 0 0
Group B1
Commensal 17 3 0 0 0 3 0 0 0 0
UPEC 4 3 1 0 0 2 0 1 0 0
NT, total isolates studied; N, number of isolates with PAIs.
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Groups B1 and A. PAI IV536 predominated in the
four groups, followed by PAI ICFT073 and, to a
lesser extent, PAI IICFT073, PAI IIJ96 and PAI I536.
PAI II536 and PAI III536 were detected only in
Group B2 isolates (Table 2). There was a positive
association between phylogenetic Group B2 and
the presence of PAIs for both commensal and
UPEC isolates (p < 0.001).
Number of accumulated PAIs per isolate in
relation to phylogenetic group
Among the commensal isolates, 22% (11 ⁄ 50) had
more than one PAI, compared with 75% (75 ⁄ 100)
of the UPEC isolates. The number of PAIs per
isolate and their distribution is shown in Table 3.
All except one Group B2 isolate had more than
one PAI. In contrast, most isolates from non-B2
groups had a maximum of two PAIs, and there
was a higher percentage (24.6%) of isolates
without PAIs. Regardless of commensal or
uropathogenic origin, the number of PAIs per
isolate showed a similar trend for phylogenetic
Groups B2 and A. Thus, both commensal and
uropathogenic E. coli isolates from Group B2
accumulated a mean of 3.9 PAIs, whereas the
mean for group A was 0.3 and 0.5 PAIs, respect-
ively. In contrast, Group D isolates showed a
mean of 0.5 and 1.3 PAIs, respectively, with a
significant difference between commensal and
UPEC isolates (5 ⁄ 14 vs. 17 ⁄ 19; p 0.009). A similar
(but non-significant) trend was also evident
among the Group B1 isolates, which showed
means of 0.2 and 1.0 PAIs (3 ⁄ 17, 18% vs. 3 ⁄ 4,
75%) for commensal and UPEC isolates, respect-
ively.
When the combination of PAIs in E. coli isolates
with the same number of PAIs was compared, it
was observed that all the isolates, except three,
had the same individual combinations (Fig. 2).
DISCUSSION
Two new multiplex PCR assays for the detection
of eight PAIs associated with pathogenic E. coli
isolates were developed for this study. PAIs were
detected in a substantial percentage of commensal
isolates (40%), although this was much lower
than the percentage for UPEC isolates (93%).
There was evidence that the intestinal niche may
harbour E. coli isolates, belonging mainly to
phylogenetic Group B2, with a large number of
accumulated PAIs. The same combination of PAIs
Table 3. Number of pathogenicity islands (PAIs) detected
in 50 commensal and 100 uropathogenic Escherichia coli
isolates, classified according to phylogenetic group
Phylogenetic
group
Number of PAIs ⁄ isolate (%)
0 1 2 3 4 5 6 7
Commensal E. coli
Group B2 – – 2(22) 3(34) – 2(22) 2(22) –
Group D 9(64) 3(22) 2(14) – – – – –
Group B1 14(82) 3(18) – – – – – –
Group A 7(70) 3(30) – – – – – –
Total 30(30) 9(9) 4(4) 3(3) 0 2(2) 2(2) 0
Uropathogenic E. coli
Group B2 – 1(1) 19(27) 17(25) 3(4) 10(15) 17(25) 2(3)
Group D 2(11) 11(58) 5(26) 1(5) – – – –
Group B1 1(25) 2(50) 1(25) – – – – –
Group A 4(50) 4(50) – – – – – –
Total 7(14) 18(36) 25(50) 18(36) 3(6) 10(20) 17(34) 2(4)
No.
PAIs
2 PAIs n = 28 
n = 1
PAI IV536
PAI ICFT073
PAI ICFT073
PAI IIJ96
3 PAIs n = 20
n = 1
PAI IV536
PAI IV536
PAI ICFT073
PAI IIJ96
PAI IICFT073
PAI I536
4 PAIs n = 3 PAI IV536 PAI ICFT073 PAI IIJ96 PAI I536
5 PAIs n = 11
n = 1
PAI IV536
PAI IV536
PAI ICFT073
PAI ICFT073
PAI IICFT073
PAI IICFT073
PAI IIJ96
PAI IIJ96
PAI I536
PAI II536
6 PAIs n = 19 PAI IV536 PAI ICFT073 PAI IICFT073 PAI IIJ96 PAI I536 PAI II536
7 PAIs n = 2 PAI IV536 PAI ICFT073 PAI IICFT073 PAI IIJ96 PAI I536 PAI II536 PAI III536
Fig. 2. Specific pathogenicity island
(PAI) combinations among the 84
Escherichia coli isolates (commensal
and uropathogenic) carrying more
than one PAI.
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was observed in E. coli isolates with an equal
number of PAIs, regardless of whether they
belonged to the same or distinct phylogenetic
groups, or whether they were obtained from
healthy females or patients with urinary tract
infection.
PAI IV536 was found most frequently in both
commensal and UPEC isolates, and is reported to
be the most ubiquitous PAI found in Enterobac-
teriaceae [17–19]. In a previous study [17], PAI
IV536, also termed High-Pathogenicity Island
(HPI), was detected in 30% of faecal E. coli
isolates, compared with 38% of isolates in the
present study. The high frequency of PAI IV536 in
commensal isolates has led to the suggestion that
HPI may be a fitness island rather than a patho-
genicity island [7,20]. However, in-vivo experi-
ments [19] have shown that HPI contributes to the
virulence of extra-intestinal pathogenic E. coli.
Middendorf et al. [21] demonstrated that PAI IV is
stable in E. coli 536, a fact that could explain its
high frequency.
The remaining PAI markers had a similar
distribution in commensal and UPEC isolates,
but with significantly higher percentages in UPEC
isolates. A previous study in urosepsis-producing
E. coli reported the presence of PAI-like domains,
with PAI IV536 in 92% of isolates, PAI IIJ96 in 24%,
PAI ICFT073 in 19% and PAI I536 in 1%, but no
evidence of PAI II536 or PAI IJ96 in any isolate,
while PAI III536 and PAI IICFT073 were not studied
[22]. The finding regarding the high frequency of
PAI IV536 is in keeping with the present study, but
there was a lower frequency of PAI I536 (19% vs.
73%), and a higher frequency of PAI IIJ96, than
PAI ICFT073. It was suggested that PAI II536 and
PAI IJ96 might not be important in the pathogen-
esis of urosepsis, but the present study found no
differences in the distribution frequency of PAI
II536 between E. coli isolated from patients with
urosepsis or pyelonephritis.
Dobrindt et al. [23] reported that 64.5% of
isolates producing urinary tract infections and
39.3% of non-pathogenic E. coli were PCR-positive
for a specific region (region 4) of PAI III536, and
concluded that PAI III536 was more common than
PAI II536 or PAI I536. The specific primers used in
the present study are included in region 4 of PAI
III536, defined by Dobrindt et al. [23], but this
region was detected in only two (2%) UPEC
isolates and in none of the commensal isolates.
Middendorf et al. [21] reported that PAIs II and III
of E. coli 536 were the most unstable, and conse-
quently easy to lose, a fact that could explain the
differences between the present findings and
those of Dobrindt et al. [23].
The distribution of phylogenetic groups differs
considerably between uropathogenic and com-
mensal E. coli isolates [4,24]. The present results
showed that Group B1 E. coli isolates were the
most prevalent (34%) among the intestinal flora,
and that Group B2 isolates were the least preval-
ent (18%), whereas this distribution was inverted
in UPEC isolates, with isolates from Group B2
being the most prevalent (69%) and those from
Group B1 being the least prevalent (5%). These
findings are in agreement with those reported by
Duriez et al. [24], who observed that Group B2
was rare among commensal E. coli isolates (11%),
whereas Groups A and B1 were the most common
(40% and 34%, respectively). The same authors
found a varying prevalence of Group B2 isolates
among commensal E. coli isolates from Mali,
France and Croatia (2%, 10.5% and 19%, respect-
ively). Similarly, Picard et al. [25] found that
Group B2 accounted for 9% of commensal human
isolates. In contrast, Zhang et al. [26] found that
this group was the most frequent among both
commensal (48%) and UPEC isolates (69%), and
suggested that the differences observed with
respect to previous results could be influenced
by the age of the healthy female population
selected for study. However, these authors stud-
ied females aged between 18 and 39 years, which
is an age range with a high incidence of urinary
tract infection in which the proportion of asymp-
tomatic carriers of uropathogenic E. coli may also
be high. In the present study, the females studied
were aged 18–50 years; hence, the differences
between the two studies cannot be explained by
the age groups selected.
A comparison of the number of accumulated
PAIs in commensal faecal and uropathogenicE. coli
isolates according to phylogenetic group showed
that the mean number of PAIs accumulated in
isolates belonging to Groups B2 and A was similar.
In contrast, pathogenic isolates from Group D
accumulated significantly more PAIs than those
from the intestinal flora, and a similar, but non-
significant, trend was observed among B1 isolates.
Duriez et al. [24] compared virulence determinants
and phylogenetic groups among commensal and
extra-intestinal pathogenic E. coli isolates and
found no significant differences in the B2 group;
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however, commensal isolates from Groups A, B1
and D appeared to possess fewer virulence deter-
minants than extra-intestinal pathogenic isolates.
The fact that commensal E. coli from groups other
than B2 are less virulent than isolates from infec-
tious processes, as observed in this and previous
studies, leads to the hypothesis that it is mainly the
most virulent isolates from these groups within the
intestine that produce urinary tract and other
infections.
Escobar et al. [27] suggested that the concen-
tration of virulence factors within Group B2
isolates is caused mainly by a genetic background
that allows numerous horizontal gene transfer
events. Insertion sequences IS1 and IS2 were
found in some PAI amplicons obtained only from
Group B2 isolates (data not shown). Such IS
elements allow recombination and, consequently,
PAI rearrangement, deletion and ⁄ or acquisition
of foreign DNA.
It is notable that the same combination of PAIs
was found among most isolates harbouring the
same number of PAIs, regardless of their origin
and phylogenetic group. Although there is an
absence of similar studies, these findings suggest
that PAI acquisition is not an arbitrary, random
event, but instead, is subject to a programmed,
sequential mechanism. It is likely that PAI IV536
was the first to be acquired and fixed on the
chromosome, making it the most stable PAI. PAI
IV536 was frequently found alone in isolates from
non-B2 groups, but with one exception, was never
alone in B2 isolates, being detected in combina-
tion with PAI ICFT073. PAI IICFT073 may have been
the third PAI to be acquired, followed by PAI IIJ96
and PAI I536. Finally, PAIs II536 and III536 would
be the last to be acquired, a fact that could explain
why they are so uncommon and found exclu-
sively in highly virulent isolates. It is noteworthy
that PAI IIJ96 was present in place of PAI IICFT073
in three isolates with four PAIs, probably because
they compete for the same tRNAphe target. Pittard
et al. [28] reported that E. coli has only two
tRNAphe genes, a fact that could increase the
degree of competition between these two PAIs.
Therefore, the results obtained suggest that
PAI IICFT073 has more affinity than PAI IIJ96 with
the target.
The classic comparisons between commensal
and extra-intestinal E. coli populations, based on a
study of O serogroups and virulence factors, have
shown that the virulence potential of E. coli
isolates from the stools of healthy individuals is
lower than that of isolates producing urinary tract
infection [3,29,30]. However, when isolates are
classified by phylogenetic group, it becomes
apparent that these differences are caused mainly
by the dissimilar distribution of E. coli popula-
tions in the intestine (where E. coli from Groups
B1 and A, characterised by few virulence factors,
are the most frequent) and the extra-intestinal
pathogenic population (where Group B2 isolates,
which accumulate a high number of virulence
factors, are the most common). Thus, it is not clear
whether all E. coli in the intestinal tract of healthy
individuals at a specific time should be consid-
ered commensal, regardless of their phylogenetic
background, or only the isolates belonging to
Groups A and B1. Similarly, it is not clear whether
E. coli isolates belonging to Groups A or B1 from a
patient with urinary tract infection should be
considered as true pathogens or as commensal E.
coli that produce infection in a compromised host.
These concepts suggest that the definition of
uropathogenic and commensal E. coli needs to
be refined further.
In conclusion, the results of this study indicate
that E. coli from Group B2 are uncommon among
commensal intestinal flora; however, when pre-
sent, they are highly virulent. These findings
suggest that the intestinal flora may act as a
reservoir, since Group B2 commensal E. coli
isolates seem to have a special privileged role in
eliciting urinary tract infection. Further in-vivo
studies are needed to fully establish and clarify
this hypothesis.
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